cbdMD Inc (YCBD)

Currency in USD
0.724
-0.026(-3.47%)
Closed·
0.710-0.014(-1.93%)
·
YCBD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.7150.790
52 wk Range
0.4702.560
Key Statistics
Prev. Close
0.724
Open
0.76
Day's Range
0.715-0.79
52 wk Range
0.47-2.56
Volume
326.51K
Average Volume (3m)
1.42M
1-Year Change
-24.2884%
Book Value / Share
0.88
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
YCBD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2.000
Upside
+176.24%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

cbdMD Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 2.000
(+176.24% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Maxim Group
Buy2.00+176.24%3.00Maintain20-08-2025

cbdMD Inc Earnings Call Summary for Q2/2026

  • Q2 FY2026 revenue rose 19% YoY to $5.6M, driven by 65% wholesale growth and Bluebird Botanicals acquisition integration.
  • Gross margin declined to 58% from 62% due to lower-margin wholesale mix and increased state regulatory compliance costs.
  • Net loss improved significantly to $0.08/share from $1.90/share YoY; cash burn reduced to $723K with $2.6M cash balance.
  • Bluebird Botanicals expected to contribute positively to earnings starting Q3 FY2026, enhancing product portfolio and market reach.
  • Management forecasts improved EBITDA and reduced working capital needs through pricing optimization and supply chain enhancements.
Last Updated: 15-05-2026, 02:40 am
Read Full Transcript

Earnings

Latest Release
14-05-2026
EPS / Forecast
-0.08 / -0.05
Revenue / Forecast
5.64M / --
EPS Revisions
Last 90 days

YCBD Income Statement

Compare YCBD to Peers and Sector

Metrics to compare
YCBD
Peers
Sector
Relationship
P/E Ratio
−2.4x−1.8x−0.5x
PEG Ratio
−0.030.010.00
Price/Book
0.8x0.9x2.6x
Price / LTM Sales
0.4x2.1x3.0x
Upside (Analyst Target)
176.2%79.5%58.6%
Fair Value Upside
Unlock−2.5%10.2%Unlock

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. It also provides products for dogs and cats, including tinctures, chews, and topicals under the Paw CBD brand name; non-cannabinoid functional ingredients, such as functional mushrooms under the ATRx brand; and hemp-derived solutions under the Herbal Oasis brand. It serves retailers, and health and pet channels through the direct-to-consumer channel, e-commerce platforms, online marketplaces, and wholesale distribution. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is based in Charlotte, North Carolina.

Employees
42

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
167.93K1.60%121.49K
Other Institutional Investors
2.51M23.94%1.82M
Public Companies & Retail Investors
7.82M74.46%5.65M
Total
10.5M100.00%7.59M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Vanguard Index Funds - Vanguard Extended Market ETF1.14%1,19,64587
Vanguard Fiduciary Trust Co. Institutional Extended Market Index Trust Fund0.45%47,15734

FAQ

What Is the cbdMD (YCBD) Share Price Today?

The cbdMD share price today is 0.724.

What is the current cbdMD (YCBD) share price and day range?

As of 08-06-2026, the cbdMD share price is 0.724, with a previous close of 0.724. The share price has ranged from 0.715 to 0.790 today, while the 52-week range spans from 0.470 to 2.560.

What Is the cbdMD Market Cap?

As of today, cbdMD market cap is 7.590M.

What Is the cbdMD (YCBD) Share Price Target?

The average 12-month share price target for cbdMD is 2.000, with a high estimate of 2 and a low estimate of 2. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +176.24% Upside potential.

What Is cbdMD's Earnings Per Share (TTM)?

The cbdMD EPS (TTM) is -0.364.

When Is the Next cbdMD Earnings Date?

cbdMD will release its next earnings report on 19-08-2026.

From a Technical Analysis Perspective, Is YCBD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

What Stock Exchange Does cbdMD Trade On?

cbdMD is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for cbdMD?

The stock symbol for cbdMD is "YCBD."

How Many Times Has cbdMD Stock Split?

cbdMD has split 2 times.

How Many Employees Does cbdMD Have?

cbdMD has 42 employees.

What Is the YCBD Premarket Price?

YCBD's last pre-market stock price is 0.710. The pre-market share volume is 3,470.000, and the stock has changed by -0.014, or -1.930%.

What Is the YCBD After Hours Price?

YCBD's last after hours stock price is 0.738, the stock has changed by 0.014, or 1.960%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.